Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS)

Soldin, 2009, Steroid hormone analysis by tandem mass spectrometry, Clin. Chem., 55, 1061, 10.1373/clinchem.2007.100008 Shackleton, 2006, Steroid profiling: diagnosis of disorders affecting steroid synthesis and metabolism, 789 Shackleton, 2008, Genetic disorders of steroid metabolism diagnosed my mass spectrometry, 549 Shackleton, 1986, Profiling steroid hormones and urinary steroids, J. Chromatogr., 379, 91, 10.1016/S0378-4347(00)80683-0 Griffiths, 2006, Steroid analysis, 447 C.H. Shackleton, Clinical steroid mass spectrometry: a 45-year history culminating in HPLC MS/MS becoming an essential tool for patient diagnosis, J. Steroid. Biochem. Mol. Biol., in press. Minutti, 2004, Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia, J. Clin. Endocrinol. Metab., 89, 3687, 10.1210/jc.2003-032235 Janzen, 2007, Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography–tandem mass spectrometry, J. Clin. Endocrinol. Metab., 92, 2581, 10.1210/jc.2006-2890 Caulfield, 2002, The diagnosis of congenital adrenal hyperplasia in the newborn by gas chromatography/mass spectrometry analysis of random urine specimens, J. Clin. Endocrinol. Metab., 87, 3682, 10.1210/jcem.87.8.8712 Wudy, 2000, Hormonal diagnosis of 21-hydroxylase deficiency in plasma and urine of neonates using benchtop gas chromatography–mass spectrometry, J. Endocrinol., 165, 679, 10.1677/joe.0.1650679 Shackleton, 1980 Peterson, 1985, Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia, N. Engl. J. Med., 313, 1182, 10.1056/NEJM198511073131903 Shackleton, 2003, Apparent pregnene hydroxylation deficiency (APHD): seeking the parentage of an orphan metabolome, Steroids, 68, 707, 10.1016/S0039-128X(03)00115-6 Fluck, 2004, Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome, Nat. Genet., 36, 228, 10.1038/ng1300 Arlt, 2004, Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study, Lancet, 363, 2128, 10.1016/S0140-6736(04)16503-3 Shackleton, 2004, Biochemical diagnosis of Antley-Bixler syndrome by steroid analysis, Am. J. Med. Genet., 128A, 223, 10.1002/ajmg.a.30104 Shackleton, 2004, Prenatal diagnosis of P450 oxidoreductase deficiency (ORD): a disorder causing low pregnancy estriol, maternal and fetal virilization, and the Antley-Bixler syndrome phenotype, Am. J. Med. Genet., 129A, 105, 10.1002/ajmg.a.30171 Wilson, 2003, 5α-Androstane-3α,17β-diol is formed in Tammar Wallaby Pouch young testes by a pathway involving 5α-pregnane-3α,17α-diol-20-one as a key intermediate, Endocrinology, 144, 575, 10.1210/en.2002-220721 Homma, 2006, Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone, J. Clin. Endocrinol. Metab., 91, 2643, 10.1210/jc.2005-2460 Shackleton, 2007, Dehydrosteroid measurements in maternal urine or serum for the prenatal diagnosis of Smith–Lemli–Opitz syndrome (SLOS), Am. J. Med. Genet., 143A, 2129, 10.1002/ajmg.a.31901 Marcos, 2009, Maternal urine and serum steroid measurements to identify steroid sulfatase deficiency (STSD) in second trimester pregnancies, Prenat. Diagn., 29, 771, 10.1002/pd.2284 Taylor, 1984, Cortisone reductase deficiency: evidence for a new inborn error of metabolism, J. Endocrinol., 102, 90 Phillipou, 1985, A new defect in the peripheral conversion of cortisone to cortisol, J. Steroid Biochem., 22, 435, 10.1016/0022-4731(85)90451-0 Phillipov, 1996, Apparent cortisone reductase deficiency: a unique form of hypercortisolism, J. Clin. Endocrinol. Metab., 81, 3855 Lavery, 2008, Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency, J. Clin. Endocrinol. Metab., 93, 3827, 10.1210/jc.2008-0743 Taylor, 2002, Validation of a high-throughput liquid chromatography–tandem mass spectrometry method for urinary cortisol and cortisone, Clin. Chem., 48, 1511, 10.1093/clinchem/48.9.1511